Roseville, MN – Tuesday, April 19, 2022 – Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, participated recently in a virtual fireside chat, “HCW @ Home”, which was hosted by H.C. Wainwright Senior Cleantech and Renewables Analyst, Amit Dayal. Representing Calyxt were Michael A. Carr, President and CEO, and William F. Koschak, CFO.
|HCW @ Home with Calyxt, Inc.|
|Date:||Monday, April18, 2022|
|Time:||12:00 p.m. ET (9:00 a.m. PT)|
|Webcast:||Link to view event|
The fireside chat is available for viewing and replay on the link above.
To schedule or learn about additional investor conversations with Calyxt, please reach out to firstname.lastname@example.org.
Calyxt (Nasdaq: CLXT) is a plant-based synthetic biology company. The Company leverages its proprietary PlantSpring™ technology platform to engineer plant metabolism to produce innovative high value plant-based chemistries for use in customers’ materials and products. As plant-based solutions, the Company’s synthetic biology products can be used in helping customers meet their sustainability targets and financial goals. Calyxt’s diversified offerings are primarily delivered through its proprietary BioFactory™ production system. For more information, visit www.calyxt.com.
PlantSpring, BioFactory, and the Calyxt logo are trademarks of Calyxt, Inc.
|Calyxt Media Contact:||Calyxt Investor Relations Contact:|
|Brennan Burks/ David Rosen/ John Garabo/ Michael Barron|
Calyxt Communications/Argot Partners
|Kimberly Minarovich/ Cameron Willis |
|Calyxt Business Development Contact:|
Senior Vice President of Business Development